Your browser version may not work well with NCBI's Web applications. More information here...
1: J Chromatogr Sci. 2008 Jan;46(1):23-9.Click here to read Links

A sensitive high-throughput HPLC assay for simultaneous determination of everolimus and clobetasol propionate.

Department of Analytical Sciences, Abbott Vascular, Inc., Santa Clara, CA 95054-2807, USA. kmarika55@hotmail.com

A novel sensitive high-throughput high-performance liquid chromatography assay is developed and validated for the simultaneous determination of everolimus and clobetasol propionate in pharmaceutical formulations. The chromatographic separation is achieved on a Zorbax Eclipse XDB-C18 reversed-phase column using a gradient elution, with solvent A: ammonium acetate (pH 6.8; 0.01 M) and solvent B: acetonitrile. The mean recovery ranges from 95.1% to 100.0% for clobetasol propionate and from 97.9% to 103.7% for everolimus. The limit of quantitation for each analyte is 0.02 microg/mL. The percent relative standard deviations are less than 3% for intra- and inter-day analyses. The proposed method can be used for the routine quality control of everolimus and clobetasol propionate in complex pharmaceutical formulations, especially the drug-delivery systems with a low total drug-load.

PMID: 18218184 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Sirolimus (Rapamune® )

    Sirolimus is used in combination with other medications to prevent rejection of kidney transplants. Sirolimus is in a class of medications called immunosuppressants. It works by suppressing the body's immune system.

  • Clobetasol (Clobevate® , Cormax® , Cormax® Scalp Application, ...)

    Clobetasol is used to treat the itching, redness, dryness, crusting, scaling, inflammation, and discomfort of various skin and scalp conditions.